Imaging Lung Tumors with Peptide-Based Radioligands

Lamberts, 1990, Somatostatin-receptor imaging in the localization of endocrine tumors, N Engl J Med, 323, 1246, 10.1056/NEJM199011013231805 Bakker, 1991, In vivo application of [111In-DTPA-DPhe1]-octreotide for detection of somatostatin receptor-positive tumors in rats, Life Sci, 49, 1593, 10.1016/0024-3205(91)90053-E Krenning, 1993, Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients, Eur J Nucl Med, 20, 716, 10.1007/BF00181765 Virgolini, 2002, In-and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial, Semin Nucl Med, 32, 148, 10.1053/snuc.2002.31565 Reubi, 2000, Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use, Eur J Nucl Med, 27, 273, 10.1007/s002590050034 Behr, 1999, Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors, J Nucl Med, 40, 1029 Gotthardt, 2002, 111In-DTPA-D-Glu1-minigastrin used for diagnosis of medullary thyroid carcinoma in comparison to 18F-FDG-PET and CT scanning, J Nucl Med, 43, 129P Reubi, 1997, Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors, Cancer Res, 57, 1377 Gotthardt, 2003, 111In-DTPA-D-Glu1-minigastrin in the diagnosis of gastroinstestinal neuroendocrine tumors: a comparison to 111In-Pentetreotide, J Nucl Med, 44, 74P Gotthardt, 2002, Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results, Eur J Nucl Med Mol Imaging, 29, 597, 10.1007/s00259-002-0761-1 Grewal, 2002, Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules, Cancer J, 8, 400, 10.1097/00130404-200209000-00011 Reubi, 1997, Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy, Q J Nucl Med, 41, 63 Behr, 2001, Imaging tumors with peptide-based radioligands, Q J Nucl Med, 45, 189 Krenning, 1992, Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide, J Nucl Med, 33, 652 Breeman, 2001, Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives, Eur J Nucl Med, 28, 1421, 10.1007/s002590100502 Kwekkeboom, 2002, Somatostatin receptor imaging, Semin Nucl Med, 32, 84, 10.1053/snuc.2002.31022 Modlin, 1997, Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today), Gastroenterology, 112, 583, 10.1053/gast.1997.v112.pm9024313 Virgolini, 1995, Vasoactive intestinal peptide receptor scintigraphy, J Nucl Med, 36, 1732 Behr, 2002, Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy. A review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg experience, Nuklearmedizin, 41, 71, 10.1055/s-0038-1625644 Reubi, 2003, Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting, Eur J Nucl Med Mol Imaging, 30, 781, 10.1007/s00259-003-1184-3 Reubi, 2002, A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors, Eur J Pharmacol, 456, 45, 10.1016/S0014-2999(02)02651-1 Jamar, 1995, Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management, J Nucl Med, 36, 542 Decristoforo, 2000, 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives, Eur J Nucl Med, 27, 1318, 10.1007/s002590000289 Sreedharan, 1989, Distinct subsets of somatostatin receptors on cultured human lymphocytes, J Biol Chem, 264, 949, 10.1016/S0021-9258(19)85035-4 Blum, 1999, The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules, Chest, 115, 224, 10.1378/chest.115.1.224 Gibril, 1999, Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas, J Nucl Med, 40, 539 Reubi, 1987, Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system, Cancer Res, 47, 5758 Reubi, 1990, Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors, Int J Cancer, 46, 416, 10.1002/ijc.2910460315 Reubi, 1990, Somatostatin receptors are present in smallcell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors, Int J Cancer, 45, 269, 10.1002/ijc.2910450211 Reubi, 1992, Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue, Gastroenterology, 103, 1207, 10.1016/0016-5085(92)91505-X Reubi, 1992, In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas, Int J Cancer, 50, 895, 10.1002/ijc.2910500613 Ricke, 2001, Standardisation of imaging in neuroendocrine tumours: results of a European delphi process, Eur J Radiol, 37, 8, 10.1016/S0720-048X(00)00187-X Ricke, 2000, Imaging procedures in neuroendocrine tumours, Digestion, 62, 39, 10.1159/000051854 Kwekkeboom, 1994, The value of octreotide scintigraphy in patients with lung cancer, Eur J Nucl Med, 21, 1106, 10.1007/BF00181066 Krenning, 1995, Somatostatin receptor scintigraphy, 1 Reisinger, 1998, Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study, J Nucl Med, 39, 224 Goldsmith, 2000, Role of nuclear medicine in the evaluation of the solitary pulmonary nodule, Semin Ultrasound CT MR, 21, 129, 10.1016/S0887-2171(00)90019-2 Fujita, 1994, Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines, Life Sci, 55, 1797, 10.1016/0024-3205(94)90090-6 Reubi, 1996, Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels, Metabolism, 45, 39, 10.1016/S0026-0495(96)90077-3 Menda, 2002, Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide, Semin Nucl Med, 32, 92, 10.1053/snuc.2002.31564 Blum, 2000, A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules, Chest, 117, 1232, 10.1378/chest.117.5.1232 Grewal, 2002, Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules, Cancer J, 8, 400, 10.1097/00130404-200209000-00011 Gambhir, 1999, Analysis of the cost-effectiveness of a somatostatin analog-99m Tc-depreotide (Neotect) in the scintigraphic evaluation of solitary pulmonary nodules (SPN), J Nucl Med, 40, 57P Tcherniantchouk, 2003, Evaluation of hila and mediastinal lymph nodes with Tc-99m depreotide in lung cancer: detection of micrometastases, J Nucl Med, 44, 135P